Caesalpinista B
Caesalpinista B is a diterpenoid compound discovered in the seeds of Caesalpinia decapetala (Roth) Alston. Caesalpinista B inhibits hepatic gluconeogenesis in a dose-dependent manner and exerts its effect even at low concentrations. Caesalpinista B is used in research related to type 2 diabetes.
For research use only. We do not sell to patients.
- CAS No.: 1140269-87-9
- Formula: C23H32O6
- Molecular Weight:404.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
In Vitro
Caesalpinista B (compound 12) (20 μM) inhibits hepatic gluconeogenesis by 106.9% in primary mouse hepatocytes[1].
Caesalpinista B (1-50 μM) inhibits hepatic gluconeogenesis in a concentration-dependent manner, and its effect at 2 μM is comparable to that of 500 μM Metformin (HY-B0627)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1140269-87-9
-
Molecular Weight 404.50
-
Formula C23H32O6
-
SMILES
C(OC(C)=O)[C@@]12[C@@]3([C@]([C@@H](C)C4=C(C3)OC=C4)(C[C@@H](O)[C@]1([C@](C(OC)=O)(C)CCC2)[H])[H])[H]
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Caesalpinista B Related Classifications
HY-N21717 Related Classifications
Powered by Bioz